# Serum Vasohibin, Cardiotrophin, Endocan & Perinatal Outcomes

> **NCT06416995** · — · RECRUITING · sponsor: **Umraniye Education and Research Hospital** · enrollment: 88 (estimated)

## Conditions studied

- Preeclampsia
- Gestational Hypertension
- Gestational Diabetes
- Preterm Birth
- Fetal Growth Retardation

## Interventions

- **DIAGNOSTIC_TEST:** first trimester serum diagnostic test

## Key facts

- **NCT ID:** NCT06416995
- **Lead sponsor:** Umraniye Education and Research Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-03
- **Primary completion:** 2024-11-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2024-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06416995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06416995, "Serum Vasohibin, Cardiotrophin, Endocan & Perinatal Outcomes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06416995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*